GlassScriptPhysician profile
Paige Nelson
NPI 1649821281
$1,365.19
in general payments reported to CMS, 2019-2025
16 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $436 · 2022: $579 · 2024: $110 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $450.21 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.99 | 2021-2022 | |
| Lilly USA, LLC | $155.62 | 2021-2025 | Ebglyss, Taltz, Olumiant |
| Novo Nordisk INC | $119.16 | 2021-2022 | |
| Ucb, INC. | $91.30 | 2024-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $72.27 | 2024-2025 | Dupixent |
| Amgen INC. | $41.58 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $38.92 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.61 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $26.06 | 2022 | |
| Janssen Biotech, INC. | $24.21 | 2025 | Stelara, Simponi, Simponi Aria |
| Genzyme Corporation | $24.21 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $18.23 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.67 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.05 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $7.10 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paige Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.